tradingkey.logo

UK's pharma regulator could issue a decision for Novo's Wegovy pill by year-end

ReutersJan 5, 2026 1:05 PM

- Britain's medicines regulator said on Monday it was reviewing Novo Nordisk's NOVOb.CO application for an oral 25 milligram version of its weight-loss drug Wegovy and anticipated making a decision before the end of the year.

Novo is launching its once-daily Wegovy pill in the United States on Monday, hoping to regain ground lost to U.S. rival Eli Lilly LLY.N and attract new, needle-wary consumers.

The Danish drugmaker has previously said it submitted applications for the pill to the European Medicines Agency and other regulatory bodies in the second half of 2025.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI